Frank BurrellScientific Storytelling
Bud BilanichSuccess Coach
Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
David LinetskyPoint-of-Care Marketing
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic ...
Clinical Trial Results Expected First Half 2019SOUTH SAN FRANCISCO, Calif., Nov. 27, 2018 (GLOBE ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email